Immunosuppressor agent derived from morbillivirus
CA 2412356 A1 · Owner: Institut National De La Sante Et De La Recherche Medicale (Inserm) · Inventors: Horvat, Branka; Kehren, Jeanne; Valentin, Helene
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the use of morbillivirus nucleoproteins or fragments thereof comprising the C-terminal portion of 100 to 130 amino acids for the preparation of immunosuppressor drugs and to the use of morbilliviruses within which the C-terminal portion has been deleted or altered for the preparation of vaccines.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 15, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 15, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 15, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.